Novonesis to buy DSM-Firmenich's stake in enzymes venture for $1.6 bln

Novozymes A/S

11/02/2025 06:26

COPENHAGEN, Feb 11 (Reuters) - Denmark's Novonesis
 NSISb.CO  said on Tuesday that it had agreed to buy the stake
of its partner, Swiss-Dutch chemical manufacturer DSM-Firmenich,
in their joint enzymes venture for 1.5 billion euros ($1.55
billion).

 (Reporting by Stine Jacobsen, editing by Terje Solsvik)
 ((stine.jacobsen@thomsonreuters.com; +45 2156 90 10;))